| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
|
4,351 |
4,120 |
$2.78M |
| 99283 |
|
9,950 |
9,611 |
$1.93M |
| 87426 |
|
5,467 |
5,313 |
$253K |
| 71045 |
|
2,417 |
2,306 |
$245K |
| 87804 |
|
9,037 |
4,634 |
$220K |
| 99282 |
|
939 |
917 |
$122K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,056 |
4,851 |
$121K |
| 87880 |
|
3,762 |
3,659 |
$88K |
| 80053 |
|
6,031 |
5,601 |
$77K |
| 85025 |
|
6,138 |
5,635 |
$53K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
579 |
571 |
$51K |
| 99285 |
|
115 |
109 |
$47K |
| 87070 |
|
3,144 |
3,060 |
$40K |
| 87428 |
|
329 |
317 |
$32K |
| 80307 |
|
203 |
193 |
$19K |
| 99213 |
|
233 |
166 |
$17K |
| 93005 |
|
900 |
833 |
$17K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
537 |
529 |
$15K |
| 96374 |
|
606 |
583 |
$13K |
| 81001 |
|
2,553 |
2,415 |
$11K |
| 83655 |
|
589 |
583 |
$11K |
| 87420 |
|
484 |
475 |
$10K |
| 80050 |
|
52 |
50 |
$9K |
| 86328 |
|
181 |
174 |
$8K |
| 83690 |
|
819 |
777 |
$6K |
| 74018 |
|
27 |
26 |
$3K |
| 81003 |
|
955 |
891 |
$3K |
| 85018 |
|
587 |
583 |
$2K |
| 96375 |
|
94 |
88 |
$2K |
| 80061 |
|
154 |
154 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
321 |
292 |
$2K |
| 86140 |
|
97 |
95 |
$1K |
| 87081 |
|
156 |
149 |
$1K |
| 83605 |
|
202 |
174 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
91 |
86 |
$1K |
| 84484 |
|
513 |
378 |
$1K |
| 96372 |
|
566 |
520 |
$1K |
| 84703 |
|
100 |
95 |
$1K |
| 84439 |
|
81 |
80 |
$978.39 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
908 |
792 |
$917.44 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
158 |
151 |
$714.76 |
| 81025 |
|
58 |
53 |
$635.18 |
| 83735 |
|
113 |
105 |
$627.41 |
| 82550 |
|
45 |
43 |
$602.98 |
| 84145 |
|
12 |
12 |
$540.61 |
| 85610 |
|
305 |
290 |
$420.37 |
| 70450 |
|
12 |
12 |
$406.57 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
143 |
138 |
$348.86 |
| 85730 |
|
220 |
212 |
$317.42 |
| 0241U |
|
757 |
736 |
$286.18 |
| 36415 |
|
8,340 |
7,464 |
$244.88 |
| 83880 |
|
59 |
53 |
$225.40 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
37 |
25 |
$169.34 |
| 84443 |
|
112 |
108 |
$151.42 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
110 |
105 |
$137.74 |
| 87086 |
|
53 |
49 |
$105.85 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
72 |
59 |
$72.58 |
| 87040 |
|
22 |
12 |
$56.55 |
| A9270 |
Non-covered item or service |
443 |
385 |
$0.00 |
| 82962 |
|
52 |
25 |
$0.00 |
| 83036 |
|
12 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
12 |
12 |
$0.00 |